study question: Do women with Turner karyotype have increased mortality and morbidity in the years after childbirth? summary answer: No mortality occurred during pregnancy and follow-up in women with Turner karyotype, but a higher rate of circulatory and endocrine diseases and a high risk of aortic aneurysm were confirmed.
Introduction
Women with Turner syndrome (TS) have three times higher mortality, high morbidity and reduced life expectancy than the general population (Price et al., 1986; Gravholt et al., 1998; Swerdlow et al., 2001; Schoemaker et al., 2008a) . Cardiac malformations, such as aortic coarctation and bicuspid aortic valves, are common in women with TS (20 -40%), as are hypertension and life-threatening aortic dissection at young age (Mazzanti and Cacciari, 1998; Gravholt et al., 2006; Sachdev et al., 2008; Donadille et al., 2012) . Hypothyroidism, diabetes mellitus and osteoporosis are also more common in women with TS (El-Mansoury et al., 2005; Freriks et al., 2011) . The severity of morbidity often depends on the karyotype, the monosomy 45,X karyotype representing the most affected women and the low-grade mosaic women representing more healthy women (El-Mansoury et al., 2007) .
The diagnosis of TS is made by karyotyping. Different X chromosome abnormalities, with loss of one X chromosome in all or part of the cell lines to abnormalities of the second X chromosome, are crucial for diagnosis. Most girls are diagnosed during infancy or childhood on the basis of stigmata, heart malformations and/or growth retardation, in adolescence when there is no onset of puberty, and in adulthood because of premature ovarian failure or infertility. Spontaneous pregnancies occur in only 2-7% (Tarani et al., 1998; Birkebaek et al., 2002; Bryman et al., 2011; Hadnott et al., 2011) and most women with TS need oocyte donation (OD) to achieve pregnancy. Pregnancies are high risk owing to increased rates of hypertensive disorders and a reported risk of aortic dissection with 2% mortality (Karnis et al., 2003; Chevalier et al., 2011; Karnis, 2012) . The possibility of normal vaginal delivery is reduced owing to cephalo-pelvic disproportion, and Caesarean section is very common (Hagman et al., 2011) . There are case reports of fatal aortic dissection both during pregnancy and shortly after delivery. The risks are elevated in both spontaneously conceived pregnancies and in pregnancies after OD (Alvaro Mercadal et al., 2011; Chevalier et al., 2011) .
Whether pregnancy and delivery carry an increased risk of mortality and morbidity in the months and years after delivery for women with TS is not known.
The aim of this study was to analyse mortality and morbidity during a follow-up period of at least 1 year after delivery in a cohort of Swedish women with Turner karyotype who gave birth in comparison with both women with Turner karyotype without childbirth and a reference population from the Medical Birth Register (MBR). The main outcome was diseases of the circulatory system.
Materials and Methods
Data on women and girls with post-natal diagnoses of Turner karyotype between 1967 and 2006 were collected from all Swedish cytogenetic laboratories (Gö teborg, Linkö ping, Lund, Skö vde, Stockholm, Umeå and Uppsala) and included in the Swedish Genetic Turner Register. The register includes data on analysing laboratory, date of birth, information on karyotype and date of diagnosis. Chromosomal analysis was mainly performed on cultures of peripheral blood lymphocytes. In some cases the analysis was also performed in fibroblasts and on buccal cells. The number of analysed cells was recorded in the majority of cases. Turner karyotype diagnosis was based on a genetic analysis of 10 -25 cells between 1967 and 1994, after which time all genetic laboratories analysed at least 30 cells when a Turner karyotype diagnosis was suspected. Turner karyotypes were divided into the following subgroups:
(1) monosomy 45,X (2) mosaic 45,X/46,XX (3) others including 45,X/46,XY 45,X/47,XXX 45,X/48,XXXX 45,X/ 49,XXXXX and isochromosomes 45,X/46,X,i(X) and 46,X,i(X), 45,X/51,XXXXXX 45,X/46der(X) (including ring chromosomes, deletions and translocations) (4) low-grade mosaic (less than 6% 45,X).
No information regarding phenotype is available in the Swedish Genetic Turner Registry.
The Swedish MBR covers nearly all deliveries in Sweden (a few percent missing) from 1973 (Cnattingius et al., 1990; National Board of Health and Welfare, 2003) . It includes information about maternal characteristics, antenatal care, delivery and neonatal data of live births and stillbirths. The definition of stillbirth until June 2008 was intrauterine fetal death after 28 completed weeks of gestation and thereafter intrauterine fetal death after 22 completed weeks of gestation.
Data on infertility treatment (IVF, OD and ovulation induction) were registered since 1994, but in some cases incompletely.
The Swedish Cause of Death Register (CDR) includes all individuals who have died either in Sweden or abroad since 1952 and who were registered in Sweden at the time of death.
The National Patient Register (NPR) includes data from all Swedish hospitals from 1987 and comprises date on hospitalization and ICD codes (International Statistical Classification of Diseases and Related Health Problems) for each occasion from 1987 to 2011. ICD-9 codes were used from 1987 to 1997 and ICD-10 codes from 1997. The NPR also contains outpatient appointments from 2001 including day surgery and psychiatric appointments with both private and public caregivers. Primary care is not yet covered in the NPR. Validation of the NPR for inpatient diagnoses was performed in 2011. Overall, the positive predictive value was found to differ between diagnoses but it was generally 85 -95% (Ludvigsson et al., 2011) . Both primary and other diagnoses were included in the present study. No outpatient data were included.
The following diagnoses were selected from the NPR (ICD 10), [ICD 9]: All diseases of the circulatory system (I00-I99), , hypertension (I10-I15), [401] [402] [403] [404] [405] , ischaemic heart disease (I20-I25), [410] [411] [412] [413] [414] , valvular disease (I33-I39), [421, 424] , arrhythmia (I44-I49), [426] [427] , aortic aneurysm (I71), [441] , cerebrovascular disease (I60-I69), [430] [431] [432] [433] [434] [435] [436] [437] [438] , thromboembolic disease including pulmonary embolism (I26, I80-82), [415, [451] [452] [453] , all heart malformations (Q20-Q26), [745] [746] [747] , aortic coarctation (Q25.1), [747B] bicuspid aortic valve (Q23.1), [746E] , all renal malformations (Q60), [753] , all endocrine, nutritional and metabolic diseases (E00-E90), , diabetes mellitus (E10-E14), [250] , all thyroid disease (E00-E07), [240] [241] [242] [243] [244] [245] [246] , hypothyreosis (E03-E04), [240] [241] 244] , thyreotoxicosis (E05), [242] , thyroiditis (E06), [245] , all gastrointestinal diseases (K70-K93), , diseases of the liver (K70-K77), [570] [571] [572] [573] , diseases of the gallbladder and pancreas (K80-K87), [574] [575] , Crohn's disease and ulcerative colitis (K50-K51), [555] [556] , epilepsy (G40-G41), [345] and osteoporosis (M80-M81), [733A] .
The Swedish Cancer Register includes ICD codes and date of diagnosis from 1958. It is compulsory for every health care provider to report newly detected cases of cancer to the register. The register includes diagnosis of (i) all definitively malignant neoplasms (ii) carcinoid tumours, granulosacell tumours of the ovary (iii) in situ malignant tumours (i.e. lip, mouth, larynx, bronchus, trachea, cervix uteri, skin, vulva, vagina and ovarian cystadenoma) and (iv) certain benign tumours (the central nervous system (CNS), meninges, all hormonally active tumours of the endocrine glands). Tumours are coded by site according to ICD. A code in the register classifies a tumour as benign or malignant.
The Swedish Genetic Turner Register was linked with the MBR to identify women with Turner karyotype born between 1957 and 1987 and who had given birth between 1973 and 2010. We excluded women born before 1957 because we only considered it reasonable to include women below 30 years of age at the time when the NPR was established in 1987. Women with Turner karyotype born between 1957 and 1987 who had never given birth were included as controls. A second control group consisting of 10 women per woman with Turner karyotype and childbirth were selected from the MBR. The controls were matched for maternal age, number of children and year of birth of the first child. Using the unique Swedish personal identification number, a linkage to the CDR, the NPR and the Cancer Register was performed.
A flow chart of the selection of women with Turner karyotype is shown in Fig. 1 .
Statistical methods
Data are presented as medians (range). Statistical analyses were performed on all Turner karyotypes and on a subgroup of all Turner karyotypes excluding low-grade mosaics. Statistical analyses were performed on main outcome, diseases of the circulatory system. In addition, statistical analyses were performed on endocrine and gastrointestinal diseases. Cox analyses were performed in order to obtain hazard ratios (HRs) [with 95% confidence intervals (CIs)] for morbidity by age-strata, and timing in relation to pregnancy. Each outcome was only counted once for each woman. Statistical analyses were performed using Gauss version 10 (Gauss TM , Aptech Systems Inc., Maple Valley, WA, USA, http://www.aptech.com).
In the analyses comparing the morbidity in women with Turner karyotype who had given birth with those who had not, stratifications were made ,40 years, and 40 years or more, respectively. In these analyses, adjustments were made for woman's year of birth.
In the comparison between women with Turner karyotype who had given birth and age-and parity-matched controls, the 'time at risk' for each woman was recorded by counting the number of days between different events:
(1) Pre-pregnancy: for each outcome studied, the number of prepregnancy days at risk was counted from 1 January 1987, when the first in-patient data were obtainable, to the estimated first day of the first pregnancy, or until the first diagnosis of the certain outcome. (2) During pregnancy and 1 year after each pregnancy: The number of days at risk was obtained by summarizing the duration of each pregnancy and 365 days after each delivery, or until the first diagnosis (for each outcome separately) if it occurred during pregnancy or within 1 year after. (3) More than 1 year after the first delivery: Excluding the days during any pregnancy and the year following each delivery, the number of days at risk was counted from the first delivery to the time of death, to diag- Figure 1 Diagram showing the study groups. The dark grey squares indicate the study groups in the comparison regarding the morbidity in women 40 years of age or more with Turner karyotype (women with childbirth versus women without childbirth) and in women 40 years or more in the MBR control group. The light grey squares indicate the study groups in the comparison between women with Turner karyotype with childbirth compared with controls. The latter groups were chosen so that their morbidity could be followed from 30 years of age, at least 3 years after their first delivery. MBR, Medical Birth Register. *Matched for woman's year of birth, year of first delivery and number of deliveries during 1973 -2010. **Seven women had the first delivery before 1987. ***70 women had the first delivery before 1987. ****All the women had their first delivery 1987 or later.
Turner karyotype: morbidity, mortality after childbirth nosis, or to the date of the data collection (31 December 2011), depending on which event happened first.
Ethical approval
The study received approvals from the Regional Ethics Committee, at the University of Gothenburg, Sweden (Dnr 004-07 and T 1121-11). No informed consent was required.
Results
We identified 502 women diagnosed with Turner karyotype (using cytogenetics) born between 1957 and 1987. One hundred and twenty-four of the women had at least one delivery between 1973 and 2010, and 378 women had not given birth. One woman with Turner karyotype and childbirth was not registered in MBR, but was identified in NPR. Therefore, the control group from MBR consisted of 1230 women. The characteristics of the study and control groups are shown in Table I Median follow-up time after first delivery was 10 years (range 1-34 years) for women with Turner karyotype and childbirth and 10 years (range 0-34 years) for the MBR control group.
Median age at follow-up on 31 December 2011 was 42 years (range 24-54 years) for women with Turner karyotype and childbirth and the MBR control group and 33 years (range 24-54 years) for women with Turner karyotype and no childbirth.
The number of women with Turner karyotype and deliveries after 1987 was 117/124 (94.4%), with a similar rate in the MBR control group (94.3%).
Mortality
No mortality was found in women with Turner karyotype and childbirth (Table II) . There were 14/378 (3.7%) deaths in women with Turner karyotype without childbirth and 9/1230 (0.7%) in the MBR control group. Causes of death in women with Turner karyotype were in 7/14 (50%) owing to diseases of the circulatory system. Five (1.3%) of the women with Turner karyotype died from aortic rupture at 25, 28, 29, 30 and 37 years of age, respectively. Two were 45,X monosomies and three belonged to the subgroup of other Turner karyotypes.
One woman in the MBR control group died within 1 year of delivery, and her diagnosis was aortic stenosis.
Morbidity
Morbidity by age at first diagnosis is shown in Tables III and IV Diseases of the circulatory system and congenital heart defects Women with Turner karyotype (with and without childbirth) had higher rates of diseases of the circulatory system than women in the MBR control group (11.0% versus 3.9%, HR 3.31; 95% CI 2.18 -5.02). This was significant for women under the age of 40 years (HR 4.59; 95% CI 2.75-7.66) but not for women at or over the age of 40 years (HR 1.48; 95% CI 0.63 -3.48).
In subgroups of women with Turner karyotype under the age of 40 years and at or over the age of 40 years, diseases of the circulatory system were similar in women with childbirth and without childbirth (11.3% versus 9.0%; HR 1.02; 95% CI 0.53 -2.25 and 1.2% versus 5.8%, HR 0.21; 95% CI 0.03-1.77, respectively).
The most common diagnosis in women with Turner karyotype was valvular disease, which occurred in 12/502 (2.4%) of all women with Turner karyotype under the age of 40 years compared with 1/1230 (0.1%) in the MBR control group. Aortic aneurysm occurred in 11/ 502 (2.2%) of all women with Turner karyotype under the age of 40 years compared with 0 women in the MBR control group.
No aortic aneurysm occurred in any group of women at or over the age of 40 years.
Two women with Turner karyotype and childbirth had an aortic aneurysm diagnosed during pregnancy at 30 and 37 years of age. One had 45,X monosomy and one belonged to the subgroup of other Turner karyotypes. Both also had cardiac defects diagnosed during the same hospitalization period (one had aortic coarctation and stenosis and one had unspecified septal defect). They were delivered by Caesarean section in gestational weeks 32 and 41 with healthy babies. One woman with mosaic karyotype and childbirth at 28 years of age was diagnosed with aortic dissection 1 month after Caesarean section in gestational week 38, also with a healthy baby. She had pre-eclampsia during pregnancy.
In addition to the five women who died, three women with Turner karyotype and no childbirth had aortic aneurysm diagnosed at 26, 30 and 34 years of age, respectively. All had 45,X monosomy. Two of the women also had aortic stenosis. The median age at diagnosis of aortic aneurysm for all women with Turner karyotype was 30 years (range 25-37 years), and 6/11 (54.5%) had 45,X monosomy.
A cardiac malformation was registered in 23/502 (4.6%) of all women with Turner karyotype under the age of 40 years compared with 3/1230 (0.2%) in the MBR control group. Aortic coarctation occurred in 13/502 (2.6%) and bicuspid aortic valve in 10/502 (2.0%) of these women.
Diseases of the circulatory system were increased overall for women with TS and childbirth compared with the MBR control group (HR 2.82; 95% CI 1.53 -5.21). They were increased before pregnancy, during any pregnancy or within 1 year after (HR 3.83; 95% CI 1.02 -14.43 and HR 5.78; 95% CI 1.94 -17.24) but not 1 or more years after delivery (HR 1.91; 95% CI 0.74-4.96).
Endocrine diseases
Women with Turner karyotype (with and without childbirth) had higher rates of endocrine, metabolic and nutritional diseases than the MBR control group (21.5% versus 5.6%, HR 2.73; 95% CI 1.86 -4.01), which was significant under the age of 40 years (20.5% versus 3.9%, HR 3.44; 2.22 -5.32) but not at or above the age of 40 years (2.7% versus 2.6%, HR 1.09; 95% CI 0.41 -2.89).
Women with Turner karyotype with and without childbirth had similar rates of endocrine, metabolic and nutritional diseases.
Thyroid disease was more common in women with Turner karyotype compared with the MBR control group (9.0% versus 2.4%, HR 3.22; 95% CI 1.88-5.34), which was significant under the age of 40 years (8.4% versus 1.4%, HR 4.47; 95% CI 2.32 -8.63) but not at or above the age of 40 years (1.6% versus 1.5%, HR 1.11; 95% CI 0.31 -3.95).
Thyroid disease was more common in women with Turner karyotype and childbirth versus women with Turner karyotype and no childbirth in women under the age of 40 years (12.2% versus 7.1%, HR 4.38; 95% CI 1.89 -10.16).
Diseases of the endocrine system were increased overall for women with TS and childbirth compared with the MBR control group (HR 3.37; 95% CI 2.02 -5.64). More thyroid diseases were also seen (HR 5.89; 95% CI 3.13 -11.08).
Endocrine diseases were increased during pregnancy or within 1 year after (HR 4.26; 95% CI 1.80 -10.08) and more thyroid diseases were also registered (HR 8.23; . No difference was seen 1 or more years after delivery.
Gastrointestinal and other diseases
Women with Turner karyotype (with and without childbirth) had similar rates of gastrointestinal diseases compared with the MBR control group (HR 1.22; 95% CI 0.83 -1.79).
Women with Turner karyotype with childbirth versus women with Turner karyotype and no childbirth had similar rates of gastrointestinal diseases (HR 1.52; 95% CI 0.77 -2.99).
In relation to pregnancy, no increase in gastrointestinal diseases was seen in women with Turner karyotype compared with the MBR control group.
Cancer
In total, malignant tumours occurred in 3/124 (2.4%) of the women with Turner karyotype and childbirth, in 11/378 (2.9%) of the women with Turner karyotype and no childbirth and in 25/1230 (2.0%) in the MBR control group (Table VII) Turner karyotype: morbidity, mortality after childbirth had ovarian cancer; both belonged to the subgroup of other Turner karyotypes. The cancer diagnoses were set after childbirth in all the three women with Turner karyotype and in 20/25 of the women from the MBR control group. Benign tumours occurred in 2.8% of all women with Turner karyotype and in 4.5% in women in the MBR control group, the most common type being cervical dysplasia.
Subgroup analysis
We performed a subgroup analysis of women with Turner karyotype, with and without childbirth, excluding the low-grade mosaics in comparison with the MBR control group. This did not change any results (data not shown).
Discussion
To our knowledge, this is the first study of health effects of pregnancy and childbirth in women with Turner karyotype. This register-based, retrospective cohort study did not identify increased mortality or morbidity in cardiovascular diseases after childbirth in women with Turner karyotype, compared with women with Turner karyotype that had not given birth.
Comparing the cohort of women with Turner karyotype with women from the general population of similar age and parity, the overall risk of diseases of the circulatory system was elevated because of valvular diseases, aortic aneurysms and cardiac malformations. The risk was even elevated already in young women under the age of 40 years. Thyroid disease was seen in more than every fifth woman with Turner karyotype. The elevated morbidity and mortality in circulatory diseases in women with Turner karyotype were not affected by pregnancy, while the incidence of thyroid disease did rise during pregnancy. Women with Turner karyotype are both more frequently affected by diseases and at younger ages.
One explanation for the findings might be that women with Turner karyotype and childbirth represent a selection of healthier Turner women. Women with Turner karyotype who had given birth were 20 years older at diagnosis than women with Turner karyotype who had not given birth. This is most probably due to less stigma in the group of women with childbirth, also indicated by their being fewer women with 45,X monosomy and more women with low-grade mosaicism compared with women without childbirth. Many of the women with Turner karyotype were not aware of their diagnosis when they delivered the first time. OD started in 2003 in Sweden, only 7 years before the present investigation was terminated. Hence, around half of the women have given birth before 2003 and might have been pregnant with natural conceptions, indicative of their being healthier women with Turner karyotype.
Aortic aneurysm is common in women with TS and occurs in all Turner karyotypes, though predominantly reported in the 45,X karyotype, and mostly in women of reproductive age. Gravholt and co-workers presented a median age of 35 years at dissection, and Carlson and Silberbach found a median age of 30.7 years, when summarizing 85 cases in the literature (Gravholt et al., 2006; Carlson and Silberbach, 2007 
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described as: hypertension, cardiac malformation, age and pregnancy. The women in this study might have had additional risk factors but it was not possible to obtain more information from the registries and no outpatient data were available. The US national guidelines 2008 and 2012 and the French guidelines 2010 state that women with TS and cardiovascular complications should be recommended to avoid pregnancy (ASRM, 2008 (ASRM, , 2012 Cabanes et al., 2010) . OD is contraindicated if the woman has certain cardiac malformations, such as aortic coarctation and bicuspid valves. These guidelines have been discussed in Sweden since the report of Karnis and co-workers in 2003 (Karnis et al., 2003) . The guidelines strongly recommend careful cardiac evaluations before and during pregnancy. These recommendations could be another reason why women with Turner karyotype and childbirth are less affected by cardiovascular events in relation to childbirth, since if a cardiac anomaly has been detected the woman might have been advised not to become pregnant. No women with childbirth in our study had a cardiac malformation diagnosed before pregnancy compared with 5.3% in women without childbirth.
The overall morbidity and mortality during .20 years of follow-up in women with Turner karyotype were elevated in comparison with controls, especially for cardiovascular disease and endocrine disease, confirming the findings from earlier epidemiological studies (Gravholt et al., 1998; El-Mansoury et al., 2005) .
The mortality in women with Turner karyotype was high during this period, and mainly attributable to diseases of the circulatory system. Among all women with Turner karyotype, 3.7% died, compared with only 0.7% among controls. 
Diseases of the circulatory system, all 14 (11.3) 1 (1.2) 34 (9.0) 6 (5.8) 48 (9.6) 7 (3. Turner karyotype: morbidity, mortality after childbirth Aortic dissection is difficult to predict. The most important issue is that women must be properly screened and evaluated for cardiac problems, preferably at centres with good knowledge about TS (Boissonnas et al., 2009; Freriks et al., 2011; Mazzanti et al., 2012) . Hypertension is common in women with TS, as are cardiac malformations. Both are reported risk factors for aortic dissection (Carlson and Silberbach, 2007) . Still there are cases of women with no known risk factors except for the Turner karyotype who die suddenly from a dissection (Bolar et al., 2008; Schoemaker et al., 2008a) .
Cardiovascular morbidity in TS is well described in the literature (Landin-Wilhelmsen et al., 2001; Volkl et al., 2005; Donadille et al., 2012; Mortensen et al., 2012) with malformations and risk of hypertension leading to ischaemic heart disease and stroke as serious events. This cohort includes younger adults, and the incidence of diseases of the circulatory system was still elevated.
In a report from Great Britain, no overall increased risk of cancer was found in women with TS compared with the general population. Site-specific risks were significantly increased for CNS tumours, bladder and urethra cancer and significantly decreased for breast cancer (Schoemaker et al., 2008b) . In our study, no increased risk of cancer was found. However, no statistical analysis was performed owing to small sample sizes.
Thyroid diseases are common in women with TS (El-Mansoury et al., 2005), which was confirmed in this study. The incidence of thyroid disease was increased in women giving birth. This could be explained to some extent by more screening for hypothyroidism in general in women with TS, especially during pregnancy or because of infertility.
Diabetes mellitus and gastrointestinal diseases were rare in our follow-up.
No registered osteoporosis was seen, which might be explained by this diagnosis mainly being determined in outpatient care. Furthermore, osteoporosis is rare in women with TS under the age of 40 years and in the childbearing ages (Landin-Wilhelmsen et al., 1999) .
The strength of the study is its register-based design, covering all cases with a known Turner karyotype in Sweden and with a large population-based MBR control group.
Limitations of the study are the selection bias, with more healthy women with Turner karyotype giving birth. Another important limitation is that no information was available about the phenotype or medical history of any of the women in the study.
The general detection bias in hospital-based studies is that the existence of one diagnosis affects the likelihood of a further diagnosis being given. Women with Turner karyotype are admitted to hospitals or other health care services more often than women from the general population, because they already suffer from one disease. Outpatient data were not available but this bias was similar for cases and controls.
It was also complicated to handle registers with data available from different time periods, the MBR from 1973 and the NPR from 1987. Hence, the follow-up is limited to a smaller cohort of all women with Turner karyotype, making statistical calculations difficult to perform.
In conclusion, no increased mortality or morbidity could be seen after pregnancies in women with Turner karyotype compared with women with Turner karyotype without childbirth, with the exception of more diagnoses of thyroid disease. 
Diseases of the general population, there was overall increased morbidity before and during pregnancy, but not in the years after pregnancy. The long-term follow-up showed increased mortality from aortic dissection in young women with Turner karyotype. A thorough cardiac evaluation in all women with Turner karyotype and especially before pregnancy is of utmost importance.
